DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /PyridinesPyridines
  6. /Pyridinium, 1-hexadecyl-2-methyl-, bromide (1:1)CAS 20667-13-4
Chemical structure of CAS 20667-13-4

Pyridinium, 1-hexadecyl-2-methyl-, bromide (1:1)

In Stock•Starting at $606 for 1 g•Purity ≥ 97%
CAS No.20667-13-4
MDL No.N/A
MFC22H40BrN
MW398.50
InChI KeyJRCWHWCFGYZDST-UHFFFAOYSA-M
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 g97%$606In Stock
5 g97%$2876In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.20667-13-4
Product NamePyridinium, 1-hexadecyl-2-methyl-, bromide (1:1)
Heavy Atom Count24Rotatable Bond Count15
Atom Stereo Count0Bond Stereo Count0
HBA0HBD0
TPSA3.880 ŲCharge0
Exact Mass397.23441Complexity377.99
pKa10.185XLogP3.768

Documentation

Similar Products

  • Pyridinium, 2-methyl-1-octyl-, bromide

    CAS No.107758-55-4

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact